YO-01027
YO-01027 (Dibenzazepine; DBZ) is a potent γ-secretase inhibitor with IC50 values of 2.92 and 2.64 nM for Notch and APPL cleavage, respectively.
Product Specifications
CAS Number
209984-56-5
Product Name Alternative
Dibenzazepine; DBZ
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Notch; γ-secretase
Type
Reference compound
Related Pathways
Neuronal Signaling; Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/YO-01027.html
Purity
99.59
Solubility
DMSO : 71.43 mg/mL (ultrasonic)
Smiles
O=C(N[C@@H](C)C(N[C@H]1C2=CC=CC=C2C3=CC=CC=C3N(C)C1=O)=O)CC4=CC(F)=CC(F)=C4
Molecular Formula
C26H23F2N3O3
Molecular Weight
463.48
Precautions
H302, H315, H319, H335
References & Citations
[1]Groth C, et al. Pharmacological analysis of Drosophila melanogaster gamma-secretase with respect to differential proteolysis of Notch and APP. Mol Pharmacol. 2010 Apr;77 (4) :567-74.|[2]Fuwa H, et al. Divergent synthesis of multifunctional molecular probes to elucidate the enzyme specificity of dipeptidic gamma-secretase inhibitors. ACS Chem Biol. 2007 Jun 15;2 (6) :408-18.|[3]Zheng YH, et al. Notch γ-secretase inhibitor dibenzazepine attenuates angiotensin II-induced abdominal aortic aneurysm in ApoE knockout mice by multiple mechanisms. PLoS One. 2013 Dec 16;8 (12) :e83310.|[4]Xiao Z, et al. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation. Int J Biochem Cell Biol. 2014 Oct;55:65-71.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881725-100 1x 100 µL
Glycophorin A / CD235a (Erythrocyte Marker) (GYPA/1725R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
